ACTIVE

OBIPHAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-1,2 k €

-118.3% YoY

Gross margin

6,3 k €

-35.0% YoY

Equity

118,8 k €

-1.0% YoY

What does OBIPHAR do?

OBIPHAR is a Public limited company incorporated in 2005. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0878.100.418

Incorporation

22/12/2005

Legal form

Public limited company

Registered office

Rue Montavaux 155
7080 Frameries · WallonieSee on map

Contributed capital

100 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	6,3 k €	-35.0%	9,7 k €	+33.3%	7,3 k €	-67.7%	22,6 k €	-0.2%	22,7 k €	-0.2%	22,7 k €	+394%	4,6 k €	-3.6%	4,8 k €	-65.1%	13,7 k €	-40.0%	22,8 k €	-0.1%	22,8 k €	-0.1%	22,8 k €	+4.4%	21,9 k €	+1.3%	21,6 k €	-5.0%	22,7 k €	+2.9%	22,1 k €	0.0%	22,1 k €	-0.1%	22,1 k €	-0.1%	22,1 k €	+6.1%	20,9 k €
EBITDA	5,9 k €	-36.6%	9,4 k €	+35.1%	6,9 k €	-68.9%	22,3 k €	-0.2%	22,3 k €	-0.2%	22,4 k €	+426%	4,2 k €	-3.9%	4,4 k €	-66.8%	13,3 k €	-40.6%	22,4 k €	-0.1%	22,5 k €	-0.1%	22,5 k €	+4.5%	21,5 k €	+1.3%	21,2 k €	-6.6%	22,7 k €	+2.9%	22,1 k €	0.0%	22,1 k €	+1.0%	21,9 k €	-0.3%	21,9 k €	+5.2%	20,9 k €
Operating result	-737 €	-108%	9,4 k €	+35.1%	6,9 k €	-68.9%	22,3 k €	-0.2%	22,3 k €	-0.2%	22,4 k €	+426%	4,2 k €	-3.9%	4,4 k €	-66.8%	13,3 k €	-40.6%	22,4 k €	+2248%	-1 k €	-2.8%	-1 k €	+48.7%	-2 k €	+12.4%	-2,3 k €	-194%	-767 €	+45.4%	-1,4 k €	0.0%	-1,4 k €	+13.6%	-1,6 k €	-4.4%	-1,6 k €	+40.9%	-2,6 k €
Net result	-1,2 k €	-118%	6,7 k €	+36.9%	4,9 k €	-70.7%	16,6 k €	-0.1%	16,6 k €	-3.3%	17,1 k €	+316%	4,1 k €	-3.9%	4,3 k €	-67.5%	13,2 k €	-40.9%	22,3 k €	+2062%	-1,1 k €	-2.9%	-1,1 k €	+48.0%	-2,1 k €	+35.2%	-3,3 k €	-11.1%	-3 k €	+37.4%	-4,7 k €	+18.2%	-5,8 k €	+17.8%	-7 k €	+10.8%	-7,9 k €	+19.3%	-9,7 k €
Balance sheet
Equity	118,8 k €	-1.0%	120,1 k €	+5.9%	113,4 k €	-23.7%	148,6 k €	+12.6%	132 k €	+14.4%	115,4 k €	+17.5%	98,3 k €	+4.4%	94,1 k €	+4.8%	89,8 k €	+17.2%	76,6 k €	+41.1%	54,3 k €	-2.1%	55,4 k €	-2.0%	56,6 k €	-3.6%	58,7 k €	-5.3%	62 k €	-4.5%	64,9 k €	-6.8%	69,6 k €	-7.6%	75,4 k €	-8.5%	82,4 k €	-8.7%	90,3 k €
Total assets	218,8 k €	+82.3%	120,1 k €	-21.7%	153,4 k €	+2.4%	149,7 k €	+12.4%	133,3 k €	+14.3%	116,6 k €	+18.5%	98,4 k €	+4.5%	94,1 k €	+1.4%	92,8 k €	+20.3%	77,2 k €	+40.7%	54,8 k €	-2.0%	56 k €	-1.3%	56,7 k €	-23.3%	74 k €	-23.8%	97,1 k €	-24.3%	128,3 k €	-20.0%	160,4 k €	-16.5%	192,1 k €	-14.3%	224 k €	-13.1%	257,9 k €
Cash	118,7 k €	+2.9%	115,3 k €	-22.3%	148,4 k €	-0.9%	149,7 k €	+12.3%	133,3 k €	+14.3%	116,6 k €	+18.5%	98,4 k €	+5.1%	93,6 k €	+1.7%	92,1 k €	+19.3%	77,2 k €	+91.4%	40,3 k €	+24.2%	32,5 k €	+1238%	2,4 k €	-30.2%	3,5 k €	+13.6%	3,1 k €	-12.4%	3,5 k €	-28.6%	4,9 k €	-12.3%	5,6 k €	-54.6%	12,3 k €	-50.2%	24,7 k €
Debts	100 k €		–		40 k €	+3242%	1,2 k €	-7.1%	1,3 k €	+11.1%	1,2 k €	+673%	150 €		–		3 k €	+485%	513 €	+0.6%	510 €	+0.8%	506 €	+233%	152 €	-99.0%	15,3 k €	-56.4%	35,1 k €	-44.6%	63,3 k €	-30.2%	90,8 k €	-22.2%	116,7 k €	-17.6%	141,6 k €	-15.5%	167,7 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 16 ended

Active mandates

FINPHARMA

Director · since 27 novembre 2023 · until 26 novembre 2029

Represented by PHILIPPE BOULANGER

Active

GESTIPHARMA

Managing director · since 27 novembre 2023 · until 26 novembre 2029 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Active

Ended mandates

ANNE RIGOLET

Director · since 30 juin 2017 · until 28 juin 2023

Ended

ANNE RIGOLET

Director · since 30 juin 2017 · until 30 juin 2023

Ended

GESTIPHARMA

Managing director · since 30 juin 2017 · until 28 juin 2023 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Ended

GESTIPHARMA

Managing director · since 30 juin 2017 · until 30 juin 2023 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended

At this address

Other companies at this address

Company	CBE no.
ASSCOT● Active	0447.778.625
ATRIUM MANAGEMENT● Active	0478.169.913
BEPHAR● Active	0450.260.538
EVRAS● Active	0417.723.174
FARMIMMO● Active	0429.198.175
FELIX PHARMA● Active	0477.939.091
IMMOBILIERE DES QUATRE SEIGNEURIES● Active	0443.155.782
Immobilière Général Léman● Active	0403.358.761
IMMOBILIERE PRIMA● Active	0466.956.812
IMMOBILIERE SAINT GEORGES● Active	0435.700.442
Les Pharmacies Réunies● Active	0403.082.213
PHARMACIE ANDROMEDE● Active	0882.318.631
PHARMACIE CLAERHOUT● Active	0423.162.203
Pharmacie de la Chasse Royale● Active	0867.368.654
PHARMACIE DE LA PLACE DE GHLIN● Active	0842.900.009
PHARMACIE FAIDHERBE● Active	0479.179.208
Pharmacie Grenez - Seeuws● Active	0419.745.130
PHARMACIE RONDEAU● Active	0447.088.737
PHARMACIE SCHNEIDER - DEPOUHON● Active	0439.400.397
PHARMANET● Active	0426.485.640

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	14/07/2025	06/08/2024	23/08/2023	16/08/2022	09/08/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	28/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	26/06/2026	30/06/2026	French	PDF
Micro model	31/12/2024	27/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	28/06/2024	06/08/2024	French	PDF
Micro model	31/12/2022	28/06/2023	23/08/2023	French	PDF
Micro model	31/12/2021	24/06/2022	16/08/2022	French	PDF
Abridged model	31/12/2020	25/06/2021	09/08/2021	French	PDF
Abridged model	31/12/2019	26/06/2020	25/08/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	07/08/2019	French	PDF
Abridged model	31/12/2017	29/06/2018	02/08/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	24/06/2016	19/07/2016	French	PDF
Abridged model	31/12/2014	26/06/2015	13/08/2015	French	PDF
Abridged model	31/12/2013	27/06/2014	22/07/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	29/07/2013	French	PDF
Abridged model	31/12/2011	29/06/2012	09/07/2012	French	PDF
Abridged model	31/12/2010	24/06/2011	08/07/2011	French	PDF
Abridged model	31/12/2009	25/06/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	26/06/2009	23/07/2009	French	PDF
Abridged model	31/12/2007	27/06/2008	23/07/2008	French	PDF
Abridged model	31/12/2006	29/06/2007	20/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 16 ended

Active mandates

FINPHARMA

Director · since 27 novembre 2023 · until 26 novembre 2029

Represented by PHILIPPE BOULANGER

Active

GESTIPHARMA

Managing director · since 27 novembre 2023 · until 26 novembre 2029 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Active

Ended mandates

ANNE RIGOLET

Director · since 30 juin 2017 · until 28 juin 2023

Ended

ANNE RIGOLET

Director · since 30 juin 2017 · until 30 juin 2023

Ended

GESTIPHARMA

Managing director · since 30 juin 2017 · until 28 juin 2023 · 0425.530.684

Represented by PIERRE PASCAL HECQ

Ended

GESTIPHARMA

Managing director · since 30 juin 2017 · until 30 juin 2023 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates25/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates27/12/2023
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates04/10/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates09/10/2017
DEMISSIONS, NOMINATIONS
PDF
Other21/10/2013
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares14/02/2012
CAPITAL, ACTIONS
PDF
Mandates11/01/2012
DEMISSIONS, NOMINATIONS
PDF
Other04/01/2006
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-1,2 k €↓
2024
Annual accounts 20246,7 k €↑
2023
Annual accounts 20234,9 k €↓
2022
Annual accounts 202216,6 k €↓
2021
Annual accounts 202116,6 k €↓
2020
Annual accounts 202017,1 k €↑
2019
Annual accounts 20194,1 k €↓
2018
Annual accounts 20184,3 k €↓
2017
Annual accounts 201713,2 k €↓
2016
Annual accounts 201622,3 k €↑
2015
Annual accounts 2015-1,1 k €↓
2014
Annual accounts 2014-1,1 k €↑
2013
Annual accounts 2013-2,1 k €↑
2012
Annual accounts 2012-3,3 k €↓
2011
Annual accounts 2011-3 k €↑
2010
Annual accounts 2010-4,7 k €↑
2009
Annual accounts 2009-5,8 k €↑
2008
Annual accounts 2008-7 k €↑
2007
Annual accounts 2007-7,9 k €↑
2006
Annual accounts 2006-9,7 k €
22/12/2005
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

OBIPHAR

Overview

What does OBIPHAR do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline